HEPARIN INDUCED THROMBOCYTOPENIA
Abstract
BACKGROUND Unfractionated heparin and low-molecular-weight-heparins are commonly prescribed drugsin everyday clinical practice for treatment or prevention of thrombotic diseases. Heparinis used also for providing patency of various catheters. Heparin seldom causes heparininduced thrombocytopenia (HIT) and concomitant activation of coagulation cascade.Activated coagulation could result in arterial or venous thrombosis. CONCLUSIONS Unrecognized HIT could be fatal. In HIT diagnostics regular follow-up of platelet values isimportant. When platelet number is decreasing, possibility of HIT should be taken intoaccount. After assessment of the clinical scoring system in HIT probable cases specific testsshould be done. When HIT is confirmed, patients should be treated with anticoagulants.Cumarins should not be used at the beginning, but later in patients with confirmed thromboticeventDownloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
